Filtered By:
Source: International Journal of Cardiology

This page shows you your search results in order of date. This is page number 11.

Order by Relevance | Date

Total 880 results found since Jan 2013.

Oxidative stress and cardiovascular risk prediction: The long way towards a “radical” perspective
ESTHER study results, published in this journal, focused on the association between two oxidative stress (OxS) biomarkers evaluated in urine (8-hydroxy-2 ′-deoxyguanosine, OxGua, and 8-isoprostane) with myocardial infarction, stroke and cardiovascular (CV) mortality in a population-based cohort of 9949 older adults from Germany during a 14 year-follow-up [1].
Source: International Journal of Cardiology - September 11, 2018 Category: Cardiology Authors: Vassalle Cristina Tags: Editorial Source Type: research

Effectiveness of CHA2DS2-VASc based decision support on stroke prevention in atrial fibrillation: A cluster randomised trial in general practice
Guidelines on atrial fibrillation (AF) recommend the CHA2DS2-VASc rule for anticoagulant decision-making, but underuse exists. We studied the impact of an automated decision support on stroke prevention in patients with AF in a cluster randomised trial in general practice.
Source: International Journal of Cardiology - September 7, 2018 Category: Cardiology Authors: S. van Doorn, F.H. Rutten, C.M. O'Flynn, R. Oudega, A.W. Hoes, K.G.M. Moons, G.J. Geersing Source Type: research

Copeptin as a prognostic biomarker in acute myocardial infarction
Copeptin - the C-terminal section of vasopressin precursor - is a novel biomarker, that has been shown to be a useful prognostic factor in heart failure, ischemic stroke and in acute myocardial infarction (MI) but with restricted population and follow-up in ST-segment elevation MI (STEMI) setting. We evaluated in this study the hypothesis that copeptin measured on admission is an independent predictor of one-year all-cause mortality after a STEMI.
Source: International Journal of Cardiology - September 6, 2018 Category: Cardiology Authors: Benoit Lattuca, Vuthy Sy, Lee Nguyen, Maguy Bernard, Michel Zeitouni, Pavel Overtchouk, Yan Yan, Nadjib Hammoudi, Alexandre Ceccaldi, Jean-Philippe Collet, Mathieu Kerneis, Abdourahmane Diallo, Gilles Montalescot, Johanne Silvain Source Type: research

One-year risks of stroke and death in patients with atrial fibrillation from different clinical settings: The Gulf SAFE registry and Darlington AF registry
Differences exist in oral anticoagulation (OAC) use between different populations with atrial fibrillation (AF), which may be associated with varying outcomes.
Source: International Journal of Cardiology - September 1, 2018 Category: Cardiology Authors: Yan-Guang Li, Kazuo Miyazawa, Andreas Wolff, Mohammad Zubaid, Alawi A. Alsheikh-Ali, Kadhim Sulaiman, Gregory Y.H. Lip Source Type: research

One-year risks of stroke and mortality in patients with atrial fibrillation from different clinical settings: The Gulf SAFE registry and Darlington AF registry
Differences exist in oral anticoagulation (OAC) use between different populations with atrial fibrillation (AF), which may be associated with varying outcomes.
Source: International Journal of Cardiology - September 1, 2018 Category: Cardiology Authors: Yan-Guang Li, Kazuo Miyazawa, Andreas Wolff, Mohammad Zubaid, Alawi A. Alsheikh-Ali, Kadhim Sulaiman, Gregory Y.H. Lip Source Type: research

Does renal function have incremental predictive value of stroke in atrial fibrillation?
It is well known that both atrial fibrillation (AF) and chronic kidney disease (CKD) are respectively independent predictors of stroke and systemic thromboembolism. A number of epidemiological and observational studies have shown that there are close relationships between AF and CKD [1 –3]. Indeed, the prevalence of AF increases from non-CKD to CKD stages of 1 to 2, 3 and 4 to 5 by 1.0%, 2.8%, 2.7%, and 4.2%, respectively [1], and the prevalence is 7% to 27% in patients with end-stage renal disease who are undergoing hemodialysis therapy [2].
Source: International Journal of Cardiology - August 28, 2018 Category: Cardiology Authors: Yukihito Higashi Tags: Editorial Source Type: research

Plasminogen activator inhibitor-1 and tissue plasminogen activator and incident AF: Data from the PREVEND study
Tissue-type plasminogen activator (TPA) and plasminogen activator inhibitor-1 (PAI-1) have been shown to be associated with increased risk for stroke, however, the association with incident atrial fibrillation (AF) is unknown.
Source: International Journal of Cardiology - August 10, 2018 Category: Cardiology Authors: Bart A. Mulder, Bastiaan Geelhoed, Pim van der Harst, Henri M. Spronk, Isabelle C. Van Gelder, Folkert W. Asselbergs, Michiel Rienstra Tags: Short communication Source Type: research

Temporal trends of the prevalence and incidence of atrial fibrillation and stroke among Asian patients with hypertrophic cardiomyopathy: A nationwide population-based study
Atrial fibrillation (AF) and stroke are common in hypertrophic cardiomyopathy (HCM). We aimed to determine the prevalence and incidence of AF and stroke in patients with HCM during a 10-year period.
Source: International Journal of Cardiology - August 10, 2018 Category: Cardiology Authors: You-Jung Choi, Eue-Keun Choi, Kyung-Do Han, Jin-Hyung Jung, Jiesuck Park, Euijae Lee, Wonseok Choe, So-Ryoung Lee, Myung-Jin Cha, Woo-Hyun Lim, Seil Oh Source Type: research

Prediction of myocardial infarction, stroke and cardiovascular mortality with urinary biomarkers of oxidative stress: Results from a large cohort study
Oxidative stress contributes to endothelial dysfunction and is involved in the pathogenesis of cardiovascular diseases (CVD). However, large population-based cohort studies are sparse and biomarkers of oxidative stress have not been evaluated for CVD risk prediction so far.
Source: International Journal of Cardiology - August 3, 2018 Category: Cardiology Authors: Yang Xuan, X īn Gào, Bernd Holleczek, Hermann Brenner, Ben Schöttker Source Type: research

Although non-stroke outcomes are more common, stroke risk scores can be used for prediction in patients with atrial fibrillation
We investigated whether cardiovascular outcome patterns differ across atrial fibrillation (AF) subgroups defined by age, valvular status, newly diagnosed vs. prevalent cases, or anticoagulation status, and whether stroke risk models can accurately predict non-stroke outcomes.
Source: International Journal of Cardiology - July 27, 2018 Category: Cardiology Authors: Finlay A. McAlister, Natasha Wiebe, Paul E. Ronksley, Jeff S. Healey Source Type: research

Comment on “Cardiovascular morbidity and mortality in patients with aortic valve sclerosis: A systematic review and meta-analysis”
With great interest, we read the recent meta- analysis written by Di Minno and colleagues [1], which assessed the association between aortic valve sclerosis (AVSc) and coronary artery disease (CAD), stroke and cardiovascular (CV) mortality. The authors concluded that AVSc screening may be of great value to be included in CV risk stratification protocols. We appreciate for the authors' thorough analysis. However, we have some concerns about the strength of their conclusion.
Source: International Journal of Cardiology - July 27, 2018 Category: Cardiology Authors: Min Zhu, Ming Li, Bin Lu Tags: Letter to the Editor Source Type: research

Incremental prognostic value of renal function for stroke prediction in atrial fibrillation
Renal function has been associated with an increased stroke risk in patients with atrial fibrillation (AF). However, whether renal function incrementally adds to risk prediction in both anticoagulated and non-anticoagulated patients with AF is unclear.
Source: International Journal of Cardiology - July 25, 2018 Category: Cardiology Authors: Emily C. O'Brien, DaJuanicia N. Holmes, Laine Thomas, Daniel E. Singer, Gregg C. Fonarow, Kenneth W. Mahaffey, Peter R. Kowey, Elaine M. Hylek, Sean D. Pokorney, Jack E. Ansell, Michael J. Pencina, Eric D. Peterson, Jonathan P. Piccini, ORBIT-AF Patients Source Type: research

Secondary stroke prevention and guideline adherent antithrombotic treatment in patients with atrial fibrillation: Insights from the Gulf Survey of atrial fibrillation events (Gulf SAFE)
Anticoagulation therapy in patients with atrial fibrillation (AF) is well established as effective thromboprophylaxis. However, AF patients with prior stroke are often treated with suboptimal antithrombotic treatment (ATT). In the present study, we investigated clinical characteristics and outcomes in AF patients with versus without prior stoke, in relation to guideline adherence in ATT.
Source: International Journal of Cardiology - July 24, 2018 Category: Cardiology Authors: Kazuo Miyazawa, Yan-Guang Li, Wafa A. Rashed, Wael Al Mahmeed, Abdullah Shehab, Mohammad Zubaid, Gregory Y.H. Lip Source Type: research

Lipid intervention in diabetes, metabolic syndrome and beyond
Substantial data during the last three decades has focused on lipid intervention for the prevention and treatment of atherosclerosis and, more importantly, on the primary and secondary prevention of major cardiovascular disease (CVD) events, including coronary heart disease (CHD) and stroke [1]. Certainly, the majority of the attention during recent decades has been directed at lowering the levels of low-density lipoprotein cholesterol (LDL-C), although some studies have also directed attention at lowering levels of triglycerides (TGs) and/or raising levels of the cardio-protective high-density lipoprotein cholesterol (HDL-C).
Source: International Journal of Cardiology - July 22, 2018 Category: Cardiology Authors: Carl J. Lavie, Richard V. Milani, James H. O'Keefe Tags: Editorial Source Type: research

Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: A Danish nationwide cohort study
Atrial fibrillation is a common cause of stroke, and diabetes increases stroke risk. Stroke risk may vary depending on the type of diabetes. We investigated whether type 1 and type 2 diabetes are associated with different risks of thromboembolism among patients with atrial fibrillation.
Source: International Journal of Cardiology - July 22, 2018 Category: Cardiology Authors: Mia V. Fangel, Peter B. Nielsen, Torben B. Larsen, Bo Christensen, Thure F. Overvad, Gregory Y.H. Lip, Samuel Z. Goldhaber, Martin B. Jensen Source Type: research